2019 News

A Deal to Fix the Broken Antibiotic Market?

The market for new antibiotics is effectively failing. No novel class of drugs for the most virulent and persistent infections, those caused by Gram negative bacteria, has entered the clinic for over 50 years, and the drugs we have are steadily...

UKI2S, Catapult Ventures and Jonathan Milner invest £500k in Gene Modulation Newcomer Pencil Biosciences

11th December, 2019, Alderley Park: UK Innovation & Science Seed Fund (UKI2S), Catapult Ventures’ GM&C Life Sciences Fund and Jonathan Milner are pleased to announced an investment in Pencil Biosciences, a novel gene modulation com...

The AMR Centre's Dr Peter Jackson in Laboratory News

Moving from Push to Pull Nothing less than an entirely new model of drug development is needed if we are to create new antibiotics says Dr Peter Jackson. And it’s something NICE are finally taking seriously as they set about developin...

AMR Centre - World Antibiotic Awareness Week

This week is World Antibiotic Awareness Week. Watch the video produced by the AMR Centre here:  

AMR Centre candidate targets superbugs with problem metallo-β-lactamase enzymes

Alderley Park, UK, 11 November 2019   The AMR Centre has nominated a preclinical candidate in its program that tackles drug resistance conferred by NDM-1 and other metallo-β-lactamases (MBL).  The MBL inhibitor (MBLI) re...

From our portfolio


Healthcare Technology

viewview our portfolio

Our Team

Nick Wright


view complete team

Contact us

Tel: 01625 344300